BALAXI PHARMACEUTICALS
|
The Current P/E Ratio of BALAXI PHARMACEUTICALS is 92.57.
| Share Price | ₹23.7 | Jul 01,2026 |
| Market Cap | ₹131.0 Cr | |
| Earnings-TTM | ₹1.4 Cr | TTM-Consolidated Results |
| Price/Earnings | 92.57x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹131.0 Cr] as on Jul 01,2026
(/) Earnings [ ₹1.4 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 92.57x ]
Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 92.57 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS
PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS
- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.25x.
- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.
- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
| Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BALAXI PHARMACEUTICALS | 1.42 | 92.57 | 131.0 |
| ADANI ENTERPRISES LTD | 9,693.51 | 42.21 | 409,155.0 |
| PREMIER ENERGIES LTD | 1,504.57 | 31.71 | 47,717.1 |
| ADITYA INFOTECH LTD | 367.96 | 114.43 | 42,107.4 |
| AEGIS LOGISTICS LTD | 1,106.63 | 39.76 | 43,999.6 |
| REDINGTON LTD | 1,284.15 | 16.67 | 21,408.9 |
| RRP SEMICONDUCTOR LTD | -7.75 | -1,578.58 | 12,240.3 |
| HONASA CONSUMER LTD | 200.33 | 75.94 | 15,213.9 |
| LLOYDS ENTERPRISES LTD | 374.53 | 30.05 | 11,255.3 |
| MMTC LTD | 212.07 | 47.86 | 10,150.5 |
| CELLO WORLD LTD | 331.51 | 24.35 | 8,073.4 |
Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -1,578.58x |
| Max industry PE | 114.43x |
| Median industry PE | 39.76x |
| Average industry PE | -96.64x |
You may also like the below Video Courses